Clinical Trial Update: Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of docetaxel and carboplatin in patients with ovarian cancer, fallopian tube cancer, or primary peritoneal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Floyd & Delores Jones Cancer Institute at Virginia Mason Medical Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED